SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: adam hefian who wrote (755)3/3/1998 11:36:00 AM
From: Vector1  Read Replies (1) | Respond to of 1826
 
Adam,
that wouldn't bother me in the least and iI would add to my position. I get worried when a biotech that will need to raise cash trades at very low levels because they are forced to sell shares at those prices making the low valuation a reality. I do not believe such a risk is high at MOGN and would view a precipitous drop as a buying opportunity. MOGN has been trading in a very wide range today. Looks to me like someone without much discipline wants out.
V1



To: adam hefian who wrote (755)3/3/1998 1:53:00 PM
From: seminole  Read Replies (1) | Respond to of 1826
 
Adam

As I have said before, I bought MOGN for the long term and
ignore daily price movement. But for those trading MOGN, price movement below the 25 day moving average has in the past given a short term sell signal. We are below this moving average and I expect
the short term money and momentum players are getting out.

richard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News